Clinical Trials Browser

Phase EARLY_PHASE1 × Neoplasms, Plasma Cell × Granulocyte Colony-Stimulating Factor × Clear all

NCT02851056 2022-11-14

Survivin Vaccine : Multiple Myeloma Autologous Hematopoietic Cell Transplant (HCT)

Phase EARLY_PHASE1 Completed

Multiple Myeloma, Neoplasms, Plasma Cell

NCT01171092 2017-01-11

A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma

Phase EARLY_PHASE1 Completed

LymphoidPlasma cell

Lymphoma, Neoplasms, Plasma Cell